Skip to content

Viracta Therapeutics, Inc.: filings

Every Viracta Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 54 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-11-13fiscal Q3 2024381090000950170-24-126385
10-Q2024-08-14fiscal Q2 2024391060000950170-24-096982
10-Q2024-05-09fiscal Q1 202438780000950170-24-057250
10-K2024-03-07fiscal FY 202339790000950170-24-027982
10-Q2023-11-09fiscal Q3 2023391100000950170-23-062145
10-Q2023-08-14fiscal Q2 2023391060000950170-23-042483
10-Q2023-05-09fiscal Q1 202337760000950170-23-019739
10-K2023-03-14fiscal FY 202238770000950170-23-007905
10-Q2022-11-10fiscal Q3 2022361030000950170-22-024539
10-Q2022-08-09fiscal Q2 202234930000950170-22-016042
10-Q2022-05-10fiscal Q1 202231650000950170-22-009031
10-K2022-03-17fiscal FY 202132660000950170-22-003991
10-Q2021-11-10fiscal Q3 202131880000950170-21-004118
10-Q2021-08-12fiscal Q2 202131800000950170-21-001376
10-Q2021-05-13fiscal Q1 202130620001193125-21-159809
10-K2021-02-24fiscal FY 202037700001564590-21-007784
10-Q2020-11-16fiscal Q3 202033800001564590-20-054194
10-Q2020-08-11fiscal Q2 202034810001564590-20-039326
10-Q2020-05-07fiscal Q1 202033610001564590-20-022937
10-K2020-03-10fiscal FY 201937700001564590-20-009783
10-Q2019-11-12fiscal Q3 201933810001564590-19-042985
10-Q2019-08-07fiscal Q2 201933810001564590-19-030130
10-Q2019-05-08fiscal Q1 201933640001564590-19-017293
10-K2019-03-07fiscal FY 201836730001564590-19-006828
10-Q2018-11-05fiscal Q3 201831780001564590-18-026884
10-Q2018-08-08fiscal Q2 201829740001564590-18-020104
10-Q2018-05-08fiscal Q1 201825510001564590-18-011879
10-K2018-03-09fiscal FY 2017341380001564590-18-005146
10-Q2017-11-02fiscal Q3 201725670001564590-17-021235
10-Q2017-07-27fiscal Q2 201725670001564590-17-014266
10-Q2017-05-08fiscal Q1 201723480001564590-17-009369
10-K2017-03-09fiscal FY 2016331350001564590-17-003862
10-Q2016-11-03fiscal Q3 201622640001564590-16-027314
10-Q2016-07-29fiscal Q2 201627840001564590-16-021786
10-Q2016-05-09fiscal Q1 201621440001564590-16-018570
10-K2016-03-14fiscal FY 2015311300001564590-16-014612
10-Q2015-11-05fiscal Q3 201522630001564590-15-009661
10-Q2015-07-30fiscal Q2 201527830001564590-15-005869
10-Q2015-05-05fiscal Q1 201522450001564590-15-003315
10-K2015-03-12fiscal FY 2014301290001564590-15-001589
10-Q2014-11-10fiscal Q3 201428840001564590-14-005430
10-Q2014-08-05fiscal Q2 201428850001193125-14-295865
10-Q2014-05-07fiscal Q1 201426530001193125-14-187522
10-K2014-03-06fiscal FY 2013331220001193125-14-086649
10-Q2013-11-12fiscal Q3 201330900001193125-13-438287
10-Q2013-08-02fiscal Q2 201331900001193125-13-317328
10-Q2013-05-09fiscal Q1 201325510001193125-13-211055
10-K2013-03-13fiscal FY 2012331190001193125-13-105232
10-Q2012-11-08fiscal Q3 201227710001193125-12-460459
10-Q2012-08-09fiscal Q2 201232900001193125-12-347564
10-Q2012-05-15fiscal Q1 201232660001193125-12-234607
10-K2012-03-14fiscal FY 201128760001193125-12-114990
10-Q2011-11-14fiscal Q3 201125660001193125-11-311186
10-Q2011-08-11fiscal Q2 201125660001193125-11-219590

Inspect the source

Entity
Viracta Therapeutics, Inc. / CIK 0001061027
Captured
2026-09-21T17:17:49.171Z
SEC response SHA-256
46e1f007a1af4059ddd3a1b769d50f0b0415de87e9fba66a6561be1394613e67

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001061027.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))